Leading cancer trials to improve treatment outcomes
Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
This study is inviting cancer patients to join important clinical trials at Case Western Reserve University to help improve treatment options and outcomes for everyone battling cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10793503 on NIH RePORTER |
What this research studies
This project focuses on the efforts of the oncology community at Case Western Reserve University and its affiliated hospitals to participate as a Lead Academic Participating Site in the National Clinical Trials Network (NCTN). The NCTN conducts large-scale clinical trials aimed at improving cancer treatment outcomes, particularly for late-phase trials that address significant scientific questions. Patients may have the opportunity to participate in these trials, which often set the standards for cancer care in the U.S. and globally. The initiative aims to enroll approximately 240 new patients each year, ensuring high-quality data generation and submission.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with various types of cancer, particularly those who may benefit from late-phase clinical trials.
Not a fit: Patients with conditions unrelated to cancer or those not eligible for clinical trials may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for cancer patients.
How similar studies have performed: Previous research within the NCTN framework has shown success in improving cancer treatment standards, indicating a strong potential for impactful outcomes.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Gerds, Aaron Thomas — Case Western Reserve University
- Study coordinator: Gerds, Aaron Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.